Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present) - ScienceDirect
$ 21.99 · 5 (494) · In stock
The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside
p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated
Synthesis and biological evaluation of dihydroquinazoline-2-amines
Indolylarylsulfones bearing phenylboronic acid and phenylboronate
Picomolar inhibitor of reverse transcriptase featuring
PDF) Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral
Targeting strategies for delivery of anti-HIV drugs - ScienceDirect
Current medicinal chemistry strategies in the discovery of novel
Novel indolylarylsulfone derivatives as covalent HIV-1 reverse
Current scenario on non-nucleoside reverse transcriptase
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief
Non-Nucleoside Reverse Transcriptase Inhibitors - an overview